Neurodegenerative and neurological injuries often feel like losing pieces of a complex puzzle—where neurons falter, inflammation surges, and energy systems break down. But a new wave of research is exploring creative strategies to protect and repair the brain and spinal cord, using tools that range from natural compounds to engineered cell therapies.
Recent studies shine light on three compelling approaches: Methylene Blue shows promise in stabilizing energy production in Huntington’s-damaged brain cells, while dihydroquercetin, a plant-based antioxidant, appears to calm inflammation and prevent nerve cell death after spinal cord injury. Meanwhile, lab-grown pericytes and their extracellular vesicles are stepping up in the fight against Alzheimer’s, helping to patch up damaged blood vessels and restore cognitive function. Together, these findings signal exciting movement toward therapies that support the brain’s natural resilience—one molecule, pathway, and cell at a time.
1. Methylene Blue Attenuates 3-Nitropropionic Acid-Induced Oxidative Stress and Mitochondrial Dysfunction in Striatal Cells: Therapeutic Implications in Huntington’s Disease Neuropathology
In an HD striatal cell model, Methylene Blue preserved mitochondrial membrane potential, restored ATP production, and modulated oxidative stress responses following 3-NPA-induced damage. These findings support its potential as a disease-modifying candidate in Huntington’s-related neurodegeneration.
2. Dihydroquercetin ameliorates spinal cord injury in rats by modulating the AKT/Nrf2/GPX4 signaling pathway-mediated ferroptosis
Oral dihydroquercetin improved motor and sensory function in SCI rats by reducing ferroptosis, oxidative stress, and neuroinflammation. These effects were mediated through activation of the AKT/Nrf2/GPX4 signaling pathway, highlighting a promising neuroprotective mechanism for post-injury recovery.
3. Intravenously injected hPSC-derived pericytes for Alzheimer disease: Neuroprotection and vascular repair via extracellular vesicles
Intravenous hPSC-derived pericytes and their extracellular vesicles restore cognition, reduce amyloid burden, and repair blood-brain barrier integrity in advanced Alzheimer’s, primarily via miRNA-486-5p-driven neurovascular signaling.
If you’d like to stay informed of the latest publications and breakthroughs in neuron regeneration, join our email newsletter to the right (or below on mobile). We send out weekly updates with the latest papers and studies, as well as podcast episodes with the people driving Neuroregenerative breakthroughs.
